O	O	0	10	Activation	Activation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T14	B-Entity	14	16	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T14	I-Entity	16	17	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T14	I-Entity	17	22	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T14	I-Entity	23	24	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	25	27	by	by	B-PP	IN	O	1	NMOD	O
T1	B-Protein	28	39	interleukin	interleukin	B-NP	NN	B-protein	7	PMOD	B-protein
T1	I-Protein	40	41	2	2	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	42	44	in	in	B-PP	IN	O	1	NMOD	O
O	O	45	50	human	human	B-NP	JJ	B-cell_type	13	NMOD	B-cell_type
O	O	51	56	blood	blood	I-NP	NN	I-cell_type	13	NMOD	I-cell_type
O	O	57	66	monocytes	monocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	66	67	.	.	O	.	O	1	P	O

O	O	69	71	We	We	B-NP	PRP	O	2	SUB	O
O	O	72	78	report	report	B-VP	VBP	O	0	ROOT	O
O	O	79	83	here	here	B-ADVP	RB	O	2	VMOD	O
O	O	84	88	that	that	B-SBAR	IN	O	2	VMOD	O
T2	B-Protein	89	100	interleukin	interleukin	B-NP	NN	B-protein	12	SUB	B-protein
T2	I-Protein	101	102	2	2	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	103	104	(	(	O	(	O	11	DEP	O
T3	B-Protein	104	106	IL	IL	B-NP	NN	B-protein	11	DEP	B-protein
T3	I-Protein	106	107	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T3	I-Protein	107	108	2	2	I-NP	CD	I-protein	8	NMOD	I-protein
O	O	108	109	)	)	O	)	O	5	NMOD	O
O	O	110	114	acts	act	B-VP	VBZ	O	4	SBAR	O
O	O	115	117	on	on	B-PP	IN	O	12	VMOD	O
O	O	118	123	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	124	129	blood	blood	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	130	139	monocytes	monocyte	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	140	142	by	by	B-PP	IN	O	12	VMOD	O
O	O	143	152	enhancing	enhance	B-VP	VBG	O	17	PMOD	O
O	O	153	160	binding	binding	B-NP	NN	O	20	NMOD	O
O	O	161	169	activity	activity	I-NP	NN	O	18	OBJ	O
O	O	170	172	of	of	B-PP	IN	O	20	NMOD	O
O	O	173	176	the	the	B-NP	DT	O	24	NMOD	O
O	O	177	190	transcription	transcription	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	191	197	factor	factor	I-NP	NN	I-protein	28	NMOD	I-protein
T15	B-Entity	198	200	NF	NF	I-NP	NN	B-protein	28	NMOD	B-protein
T15	I-Entity	200	201	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T15	I-Entity	201	206	kappa	kappa	I-NP	NN	I-protein	28	NMOD	I-protein
T15	I-Entity	207	208	B	B	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	209	211	to	to	B-PP	TO	O	18	VMOD	O
O	O	212	215	its	its	B-NP	PRP$	O	32	NMOD	O
O	O	216	225	consensus	consensus	I-NP	NN	B-DNA	32	NMOD	B-DNA
O	O	226	234	sequence	sequence	I-NP	NN	I-DNA	29	PMOD	I-DNA
O	O	235	237	in	in	B-PP	IN	O	32	NMOD	O
O	O	238	241	the	the	B-NP	DT	O	39	NMOD	O
T16	B-Entity	242	243	5	5	I-NP	CD	B-DNA	39	NMOD	B-DNA
T16	I-Entity	243	244	'	'	I-NP	SYM	I-DNA	39	NMOD	I-DNA
T16	I-Entity	245	255	regulatory	regulatory	I-NP	JJ	I-DNA	39	NMOD	I-DNA
T16	I-Entity	256	264	enhancer	enhancer	I-NP	NN	I-DNA	39	NMOD	I-DNA
T16	I-Entity	265	271	region	region	I-NP	NN	I-DNA	33	PMOD	I-DNA
O	O	272	274	of	of	B-PP	IN	O	39	NMOD	O
O	O	275	278	the	the	B-NP	DT	O	47	NMOD	O
T4	B-Protein	279	281	IL	IL	I-NP	NN	B-protein	47	NMOD	B-protein
T4	I-Protein	281	282	-	-	B-NP	HYPH	I-protein	47	NMOD	I-protein
T4	I-Protein	282	283	2	2	I-NP	CD	I-protein	47	NMOD	I-protein
T4	I-Protein	284	292	receptor	receptor	I-NP	NN	I-protein	47	NMOD	I-protein
T4	I-Protein	293	298	alpha	alpha	I-NP	NN	I-protein	47	NMOD	I-protein
T4	I-Protein	299	304	chain	chain	I-NP	NN	I-protein	40	PMOD	I-protein
O	O	305	306	(	(	O	(	O	50	DEP	O
T5	B-Protein	306	309	p55	p55	B-NP	NN	B-protein	50	DEP	B-protein
O	O	309	310	)	)	O	)	O	47	NMOD	O
O	O	310	311	.	.	O	.	O	2	P	O

O	O	312	321	Similarly	Similarly	B-ADVP	RB	O	6	VMOD	O
O	O	321	322	,	,	O	,	O	6	P	O
T6	B-Protein	323	325	IL	IL	B-NP	NN	B-protein	6	SUB	B-protein
T6	I-Protein	325	326	-	-	O	HYPH	I-protein	3	NMOD	I-protein
T6	I-Protein	326	327	2	2	B-NP	CD	I-protein	3	NMOD	I-protein
O	O	328	337	activates	activate	B-VP	VBZ	O	0	ROOT	O
T17	B-Entity	338	340	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T17	I-Entity	340	341	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T17	I-Entity	341	346	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T17	I-Entity	347	348	B	B	I-NP	NN	I-protein	6	OBJ	I-protein
O	O	349	351	in	in	B-PP	IN	O	6	VMOD	O
O	O	352	355	the	the	B-NP	DT	O	17	NMOD	O
O	O	356	361	human	human	I-NP	JJ	B-cell_line	17	NMOD	B-cell_line
O	O	362	371	monocytic	monocytic	I-NP	JJ	I-cell_line	17	NMOD	I-cell_line
O	O	372	376	cell	cell	I-NP	NN	I-cell_line	17	NMOD	I-cell_line
O	O	377	381	line	line	I-NP	NN	I-cell_line	17	NMOD	I-cell_line
O	O	382	383	U	U	I-NP	NN	I-cell_line	11	PMOD	I-cell_line
O	O	384	387	937	937	I-NP	CD	I-cell_line	17	NMOD	I-cell_line
O	O	387	388	,	,	B-PP	,	O	11	P	O
O	O	389	392	but	but	I-PP	CC	O	11	PMOD	O
O	O	393	396	not	not	B-PP	RB	O	22	PMOD	O
O	O	397	399	in	in	I-PP	IN	O	11	PMOD	O
O	O	400	407	resting	rest	B-VP	VBG	B-cell_type	27	NMOD	B-cell_type
O	O	408	413	human	human	B-NP	JJ	I-cell_type	27	NMOD	I-cell_type
O	O	414	415	T	T	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	415	416	-	-	I-NP	HYPH	I-cell_type	27	NMOD	I-cell_type
O	O	416	421	cells	cell	B-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	421	422	.	.	O	.	O	6	P	O

O	O	423	427	This	This	B-NP	DT	O	2	NMOD	O
O	O	428	434	effect	effect	I-NP	NN	O	3	SUB	O
O	O	435	437	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	438	448	detectable	detectable	B-ADJP	JJ	O	3	PRD	O
O	O	449	455	within	within	B-PP	IN	O	3	VMOD	O
O	O	456	458	15	15	B-NP	CD	O	7	NMOD	O
O	O	459	462	min	min	I-NP	NN	O	5	PMOD	O
O	O	463	466	and	and	O	CC	O	3	VMOD	O
O	O	467	472	peaks	peak	B-VP	VBZ	O	3	VMOD	O
O	O	473	474	1	1	B-NP	CD	O	11	NMOD	O
O	O	475	476	h	h	I-NP	NN	O	12	PMOD	O
O	O	477	482	after	after	B-PP	IN	O	9	VMOD	O
O	O	483	491	exposure	exposure	B-NP	NN	O	12	PMOD	O
O	O	492	494	to	to	B-PP	TO	O	13	NMOD	O
T7	B-Protein	495	497	IL	IL	B-NP	NN	B-protein	14	PMOD	B-protein
T7	I-Protein	497	498	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T7	I-Protein	498	499	2	2	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	499	500	.	.	O	.	O	3	P	O

O	O	501	509	Enhanced	Enhance	B-NP	VBN	O	7	NMOD	O
T18	B-Entity	510	512	NF	NF	I-NP	NN	B-protein	7	NMOD	B-protein
T18	I-Entity	512	513	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T18	I-Entity	513	518	kappa	kappa	I-NP	NN	I-protein	7	NMOD	I-protein
T18	I-Entity	519	520	B	B	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	521	528	binding	binding	I-NP	NN	O	7	NMOD	O
O	O	529	537	activity	activity	I-NP	NN	O	8	SUB	O
O	O	538	540	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	541	549	followed	follow	I-VP	VBN	O	8	VC	O
O	O	550	552	by	by	B-PP	IN	O	9	VMOD	O
O	O	553	563	functional	functional	B-NP	JJ	O	12	NMOD	O
O	O	564	574	activation	activation	I-NP	NN	O	10	PMOD	O
O	O	575	577	in	in	B-PP	IN	O	12	NMOD	O
O	O	578	582	that	that	B-NP	DT	O	15	NMOD	O
O	O	583	595	inducibility	inducibility	I-NP	NN	O	13	PMOD	O
O	O	596	598	of	of	B-PP	IN	O	15	NMOD	O
O	O	599	602	the	the	B-NP	DT	O	23	NMOD	O
T8	B-Protein	603	605	IL	IL	I-NP	NN	B-protein	23	NMOD	B-protein
T8	I-Protein	605	606	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T8	I-Protein	606	607	2	2	I-NP	CD	I-protein	23	NMOD	I-protein
T8	I-Protein	608	616	receptor	receptor	I-NP	NN	I-protein	23	NMOD	I-protein
T8	I-Protein	617	622	alpha	alpha	I-NP	NN	I-protein	23	NMOD	I-protein
T8	I-Protein	623	628	chain	chain	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	629	631	is	be	B-VP	VBZ	O	8	VMOD	O
O	O	632	640	mediated	mediate	I-VP	VBN	O	24	VC	O
O	O	641	643	by	by	B-PP	IN	O	25	VMOD	O
O	O	644	652	enhanced	enhance	B-NP	VBN	O	32	NMOD	O
T19	B-Entity	653	655	NF	NF	I-NP	NN	B-protein	32	NMOD	B-protein
T19	I-Entity	655	656	-	-	B-NP	HYPH	I-protein	32	NMOD	I-protein
T19	I-Entity	656	661	kappa	kappa	I-NP	NN	I-protein	32	NMOD	I-protein
T19	I-Entity	662	663	B	B	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	664	671	binding	binding	I-NP	NN	O	26	PMOD	O
O	O	672	675	and	and	O	CC	O	34	DEP	O
O	O	676	680	that	that	B-SBAR	IN	O	24	VMOD	O
O	O	681	682	a	a	B-NP	DT	O	37	NMOD	O
O	O	683	695	heterologous	heterologous	I-NP	JJ	B-DNA	37	NMOD	B-DNA
O	O	696	704	promoter	promoter	I-NP	NN	I-DNA	62	SUB	I-DNA
O	O	705	715	containing	contain	B-VP	VBG	O	37	NMOD	O
O	O	716	719	the	the	B-NP	DT	O	45	NMOD	O
T20,T21	B-Entity,B-Entity	720	722	NF	NF	I-NP	NN	B-DNA	45	NMOD	B-DNA
T20,T21	I-Entity,I-Entity	722	723	-	-	B-NP	HYPH	I-DNA	45	NMOD	I-DNA
T20,T21	I-Entity,I-Entity	723	728	kappa	kappa	I-NP	NN	I-DNA	45	NMOD	I-DNA
T20,T21	I-Entity,I-Entity	729	730	B	B	I-NP	NN	I-DNA	45	NMOD	I-DNA
T20	I-Entity	731	740	consensus	consensus	I-NP	NN	I-DNA	45	NMOD	I-DNA
T20	I-Entity	741	749	sequence	sequence	I-NP	NN	I-DNA	38	OBJ	I-DNA
O	O	750	751	(	(	O	(	O	52	DEP	O
T22	B-Entity	751	752	-	-	B-NP	SYM	B-DNA	51	NMOD	B-DNA
T22	I-Entity	752	755	291	291	B-NP	CD	I-DNA	51	NMOD	I-DNA
T22	I-Entity	756	758	to	to	B-PP	TO	I-DNA	51	NMOD	I-DNA
T22	I-Entity	759	760	-	-	B-NP	SYM	I-DNA	51	NMOD	I-DNA
T22	I-Entity	760	763	245	245	I-NP	CD	I-DNA	52	DEP	I-DNA
O	O	763	764	)	)	O	)	O	45	NMOD	O
O	O	765	767	of	of	B-PP	IN	O	45	NMOD	O
O	O	768	771	the	the	B-NP	DT	O	61	NMOD	O
T9	B-Protein	772	774	IL	IL	I-NP	NN	B-DNA	61	NMOD	B-DNA
T9	I-Protein	774	775	-	-	B-NP	HYPH	I-DNA	61	NMOD	I-DNA
T9	I-Protein	775	776	2	2	I-NP	CD	I-DNA	61	NMOD	I-DNA
T9	I-Protein	777	785	receptor	receptor	I-NP	NN	I-DNA	61	NMOD	I-DNA
T9	I-Protein	786	791	alpha	alpha	I-NP	NN	I-DNA	61	NMOD	I-DNA
T9	I-Protein	792	797	chain	chain	I-NP	NN	I-DNA	61	NMOD	I-DNA
O	O	798	802	gene	gene	I-NP	NN	I-DNA	53	PMOD	I-DNA
O	O	803	805	is	be	B-VP	VBZ	O	34	SBAR	O
O	O	806	815	activated	activate	I-VP	VBN	O	62	VC	O
O	O	815	816	.	.	O	.	O	8	P	O

O	O	817	819	In	In	B-PP	IN	O	7	VMOD	O
O	O	820	828	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	828	829	,	,	O	,	O	7	P	O
T10	B-Protein	830	832	IL	IL	B-NP	NN	B-protein	5	NMOD	B-protein
T10	I-Protein	832	833	-	-	O	HYPH	I-protein	7	SUB	I-protein
T10	I-Protein	833	834	2	2	B-NP	CD	I-protein	5	NMOD	I-protein
O	O	835	837	is	be	B-VP	VBZ	O	31	VMOD	O
O	O	838	845	capable	capable	B-ADJP	JJ	O	7	PRD	O
O	O	846	848	of	of	B-PP	IN	O	8	AMOD	O
O	O	849	859	increasing	increase	B-VP	VBG	O	9	PMOD	O
O	O	860	870	transcript	transcript	B-NP	NN	O	12	NMOD	O
O	O	871	877	levels	level	I-NP	NNS	O	10	OBJ	O
O	O	878	880	of	of	B-PP	IN	O	12	NMOD	O
O	O	881	884	the	the	B-NP	DT	O	16	NMOD	O
T11	B-Protein	885	888	p50	p50	I-NP	NN	B-DNA	16	NMOD	B-DNA
O	O	889	893	gene	gene	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	894	900	coding	cod	B-VP	VBG	O	16	NMOD	O
O	O	901	904	for	for	B-PP	IN	O	17	VMOD	O
O	O	905	908	the	the	B-NP	DT	O	21	NMOD	O
T12	B-Protein	909	912	p50	p50	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	913	920	subunit	subunit	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	921	923	of	of	B-PP	IN	O	21	NMOD	O
O	O	924	927	the	the	B-NP	DT	O	29	NMOD	O
T23	B-Entity	928	930	NF	NF	I-NP	NN	B-protein	29	NMOD	B-protein
T23	I-Entity	930	931	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T23	I-Entity	931	936	kappa	kappa	I-NP	NN	I-protein	29	NMOD	I-protein
T23	I-Entity	937	938	B	B	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	939	952	transcription	transcription	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	953	959	factor	factor	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	959	960	,	,	O	,	O	31	P	O
O	O	961	968	whereas	whereas	O	IN	O	0	ROOT	O
O	O	969	973	mRNA	mRNA	B-NP	NN	B-RNA	33	NMOD	B-RNA
O	O	974	980	levels	level	I-NP	NNS	O	42	SUB	O
O	O	981	983	of	of	B-PP	IN	O	33	NMOD	O
O	O	984	987	the	the	B-NP	DT	O	41	NMOD	O
T13	B-Protein	988	991	p65	p65	I-NP	NN	B-protein	37	NMOD	B-protein
T24	B-Entity	992	994	NF	NF	I-NP	NN	I-protein	41	NMOD	I-protein
T24	I-Entity	994	995	-	-	B-NP	HYPH	O	41	NMOD	O
T24	I-Entity	995	1000	kappa	kappa	I-NP	NN	B-DNA	41	NMOD	B-DNA
T24	I-Entity	1001	1002	B	B	I-NP	NN	I-DNA	41	NMOD	I-DNA
T24	I-Entity	1003	1007	gene	gene	I-NP	NN	I-DNA	34	PMOD	I-DNA
O	O	1008	1016	remained	remain	B-VP	VBD	O	31	VMOD	O
O	O	1017	1026	unchanged	unchanged	B-ADJP	JJ	O	42	PRD	O
O	O	1026	1027	.	.	O	.	O	31	P	O
